{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:30:09Z","timestamp":1777480209287,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09504-x","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:06:16Z","timestamp":1771031176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of chitosan supplementation versus placebo on liver fat and metabolic parameters in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol"],"prefix":"10.1186","volume":"27","author":[{"given":"Mahsa","family":"Rouini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadis","family":"Alimoradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Chamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Sadat","family":"Hashemi Javaheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nematy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Falahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"6","key":"9504_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biom12060824","volume":"12","author":"F Nassir","year":"2022","unstructured":"Nassir F. NAFLD: mechanisms, treatments, and biomarkers. Biomolecules. 2022;12(6):824.","journal-title":"Biomolecules"},{"issue":"4","key":"9504_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"2","key":"9504_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5009\/gnl20127","volume":"15","author":"S Murag","year":"2020","unstructured":"Murag S, Ahmed A, Kim D. Recent epidemiology of nonalcoholic fatty liver disease. Gut Liver. 2020;15(2):206.","journal-title":"Gut Liver"},{"issue":"8","key":"9504_CR4","first-page":"1600","volume":"52","author":"S Hassanipour","year":"2023","unstructured":"Hassanipour S, Amini-Salehi E, Joukar F, Khosousi M-J, Pourtaghi F, Ansar MM, et al. The prevalence of non-alcoholic fatty liver disease in iranian children and adult population: a systematic review and meta-analysis. Iran J Public Health. 2023;52(8):1600.","journal-title":"Iran J Public Health"},{"key":"9504_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0391-9","volume":"16","author":"J Liang","year":"2018","unstructured":"Liang J, Liu Y, Liu J, Li Z, Fan Q, Jiang Z, et al. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD. J Nanobiotechnology. 2018;16:1\u201312.","journal-title":"J Nanobiotechnology"},{"key":"9504_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2021.110507","volume":"153","author":"W El-Sayed","year":"2021","unstructured":"El-Sayed W, Alkabli J, Aloqbi A, Elshaarawy RF. Optimization enzymatic degradation of chitosan into amphiphilic chitooligosaccharides for application in mitigating liver steatosis and cholesterol regulation. Eur Polym J. 2021;153:110507.","journal-title":"Eur Polym J"},{"issue":"3","key":"9504_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13659","volume":"52","author":"N Pugliese","year":"2022","unstructured":"Pugliese N, Plaz Torres MC, Petta S, Valenti L, Giannini EG, Aghemo A. Is there an \u2018ideal\u2019diet for patients with NAFLD? Eur J Clin Invest. 2022;52(3):e13659.","journal-title":"Eur J Clin Invest"},{"issue":"22","key":"9504_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nu16223958","volume":"16","author":"D Niv","year":"2024","unstructured":"Niv D, Anavi E, Yaval L, Abbas A, Rytwo G, Gutman R. Sepiolite\u2013Chitosan\u2013Acetic acid biocomposite attenuates the development of obesity and nonalcoholic fatty liver disease in mice fed a high-fat diet. Nutrients. 2024;16(22):3958.","journal-title":"Nutrients"},{"issue":"18","key":"9504_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ani12182465","volume":"12","author":"W Tao","year":"2022","unstructured":"Tao W, Jin F, Fan Q, Zhao N, Wang G, Du E, et al. Effects of chitosan oligosaccharide on production performance, egg quality and ovarian function in laying hens with fatty liver syndrome. Animals. 2022;12(18):2465.","journal-title":"Animals"},{"issue":"11","key":"9504_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/md16110455","volume":"16","author":"Y Bai","year":"2018","unstructured":"Bai Y, Zheng J, Yuan X, Jiao S, Feng C, Du Y, et al. Chitosan oligosaccharides improve glucolipid metabolism disorder in liver by suppression of obesity-related inflammation and restoration of peroxisome proliferator-activated receptor gamma (PPAR\u03b3). Mar Drugs. 2018;16(11):455.","journal-title":"Mar Drugs"},{"issue":"11","key":"9504_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/md17110645","volume":"17","author":"W Tao","year":"2019","unstructured":"Tao W, Sun W, Liu L, Wang G, Xiao Z, Pei X, et al. Chitosan oligosaccharide attenuates nonalcoholic fatty liver disease induced by high fat diet through reducing lipid accumulation, inflammation and oxidative stress in C57BL\/6 mice. Mar Drugs. 2019;17(11):645.","journal-title":"Mar Drugs"},{"issue":"8","key":"9504_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081497","volume":"12","author":"R Lan","year":"2023","unstructured":"Lan R, Luo H, Wu F, Wang Y, Zhao ZJA. Chitosan oligosaccharides alleviate heat-stress-induced lipid metabolism disorders by suppressing the oxidative stress and inflammatory response in the liver of broilers. Antioxidants. 2023;12(8):1497.","journal-title":"Antioxidants"},{"issue":"6","key":"9504_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41575-018-0007-8","volume":"15","author":"A Mardinoglu","year":"2018","unstructured":"Mardinoglu A, Boren J, Smith U, Uhlen M, Nielsen J. Systems biology in hepatology: approaches and applications. Nature Reviews Gastroenterology & Hepatology. 2018;15(6):365\u201377.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"8","key":"9504_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65(8):1109\u201323.","journal-title":"Metabolism"},{"key":"9504_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/md17110645","author":"W Tao","year":"2019","unstructured":"Tao W, Sun W, Liu L, Wang G, Xiao Z, Pei X, et al. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL\/6 Mice. Mar Drugs. 2019. https:\/\/doi.org\/10.3390\/md17110645.","journal-title":"Mar Drugs"},{"issue":"1","key":"9504_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.21608\/bvmj.2015.32730","volume":"28","author":"OAR AboZaid","year":"2015","unstructured":"AboZaid OAR, AbdEl-hamid OM, Atwa SAE. Hypolipidemic and anti-inflammatory effect of chitosan in experimental induced non -alcoholic fatty liver disease in rats. Benha Vet Med J. 2015;28(1):155\u201365.","journal-title":"Benha Vet Med J"},{"issue":"10","key":"9504_CR17","doi-asserted-by":"publisher","first-page":"9465","DOI":"10.1007\/s11033-022-07810-6","volume":"49","author":"R Kumar","year":"2022","unstructured":"Kumar R, Arya JK, Rizvi SI. Chitosan reduces inflammation and protects against oxidative stress in a hyperlipidemic rat model: relevance to nonalcoholic fatty liver disease. Mol Biol Rep. 2022;49(10):9465\u201372.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"9504_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031139","volume":"22","author":"S-H Liu","year":"2021","unstructured":"Liu S-H, Chen R-Y, Chiang M-T. Effects and mechanisms of chitosan and chitosanoligosaccharide on hepatic lipogenesis and lipid peroxidation, adipose lipolysis, and intestinal lipid absorption in rats with high-fat diet-induced obesity. Int J Mol Sci. 2021;22(3):1139.","journal-title":"Int J Mol Sci"},{"key":"9504_CR19","unstructured":"Mohamed MM. Effects of chitosan and wheat bran on serum leptin, TNF-\u03b1, lipid profile and oxidative status in animal model of non-alcoholic fatty liver. Aust. J. Basic Appl. Sci. 2011;5:1478\u201388."},{"key":"9504_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/md17070391","author":"M Qian","year":"2019","unstructured":"Qian M, Lyu Q, Liu Y, Hu H, Wang S, Pan C, et al. Chitosan oligosaccharide ameliorates nonalcoholic fatty liver disease (NAFLD) in diet-induced obese mice. Mar Drugs. 2019. https:\/\/doi.org\/10.3390\/md17070391.","journal-title":"Mar Drugs"},{"issue":"3","key":"9504_CR21","first-page":"3211","volume":"18","author":"ZF Wang","year":"2018","unstructured":"Wang ZF, Wang MY, Yu DH, Zhao Y, Xu HM, Zhong S, et al. Therapeutic effect of chitosan on CCl4-induced hepatic fibrosis in rats. Mol Med Rep. 2018;18(3):3211\u20138.","journal-title":"Mol Med Rep"},{"issue":"2","key":"9504_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/nu9020096","volume":"9","author":"Q Chen","year":"2017","unstructured":"Chen Q, Wang T, Li J, Wang S, Qiu F, Yu H, et al. Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD). Nutrients. 2017;9(2):96.","journal-title":"Nutrients"},{"issue":"3","key":"9504_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nutres.2012.02.004","volume":"32","author":"EH Choi","year":"2012","unstructured":"Choi EH, Yang HP, Chun HS. Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation. Nutr Res. 2012;32(3):218\u201328.","journal-title":"Nutr Res"},{"issue":"3","key":"9504_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24030514","volume":"24","author":"D Yang","year":"2019","unstructured":"Yang D, Hu C, Deng X, Bai Y, Cao H, Guo J, et al. Therapeutic effect of chitooligosaccharide tablets on lipids in high-fat diets induced hyperlipidemic rats. Molecules. 2019;24(3):514.","journal-title":"Molecules"},{"key":"9504_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u201341.","journal-title":"Free Radic Biol Med"},{"issue":"1-2","key":"9504_CR26","first-page":"12","volume":"690","author":"J Kim","year":"2010","unstructured":"Kim J, Cha YN, Surh YJ. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res. 2010;690(1\u20132):12\u201323.","journal-title":"Mutat Res"},{"issue":"4","key":"9504_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1134\/S0006297911040031","volume":"76","author":"VO Tkachev","year":"2011","unstructured":"Tkachev VO, Menshchikova EB, Zenkov NK. Mechanism of the Nrf2\/Keap1\/ARE signaling system. Biochemistry (Mosc). 2011;76(4):407\u201322.","journal-title":"Biochemistry (Mosc)"},{"key":"9504_CR28","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.carbpol.2017.07.051","volume":"174","author":"Q Xu","year":"2017","unstructured":"Xu Q, Liu M, Liu Q, Wang W, Du Y, Yin H. The inhibition of LPS-induced inflammation in RAW264.7 macrophages via the PI3K\/Akt pathway by highly N-acetylated chitooligosaccharide. Carbohydr Polym. 2017;174:1138\u201343.","journal-title":"Carbohydr Polym"},{"issue":"7","key":"9504_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.81","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon SM. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016;48(7):e245.","journal-title":"Exp Mol Med"},{"issue":"Pt 1","key":"9504_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1113\/jphysiol.2006.108506","volume":"574","author":"B Viollet","year":"2006","unstructured":"Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, et al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol. 2006;574(Pt 1):41\u201353.","journal-title":"J Physiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09504-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09504-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09504-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:41:05Z","timestamp":1774885265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09504-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9504"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09504-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol is approved by the Ethics Committee on Lorestan University of Medical Sciences (IR.LUMS.REC.1403.341, 26-November-2024). All significant protocol modifications must be approved by the Ethics Committee on Biomedical Research and communicated to relevant parties. The Ethics Committee on Biomedical Research at Lorestan University of Medical Sciences will perform audits every 12\u00a0months, during which the study progress reports will be reviewed and recommendations for the next research plans will be provided. Guardians provide written, informed consent for their children to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent will be obtained by trained research staff under the supervision of the principal investigator prior to any study procedures. No ancillary studies involving additional data or biological specimen collection are planned. Therefore, no additional consent beyond the main informed consent is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}